Published in Vaccine Weekly, July 8th, 2009
"Although both vectors induced a similar OVA-specific CD8(+) T-cell response in the long term, LM-OVA induced mainly central-phenotype (T-CM, CD44(high)CD62L(high)), whereas ST-OVA induced mainly effector-phenotype (T-EM, CD44(high)CD62L(low)) cells. Both...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-07-08)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.